Discover
CNSP
CNS Pharmaceuticals, Inc.
5.39
1 x 5.20
1 x 6.02
bid
ask
+
0.00
0.00%
2 @ 08:37 AM
5.15 -0.24 (4.38%)
| Ytd | 2.67% | |
| 1y | -39.71% |
day range
1.90
52 week range
10.59
| Open | Prev Close | 5.39 | Low | High | Mkt Cap | 3.10M | |||
| Vol | 0.00 | Avg Vol | 1.43M | EPS | -24.57 | P/E | -0.22 | Forward P/E | -0.28 |
| Beta | 3.06 | Short Ratio | 0.04 | Inst. Own | 0.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 5.00 | 200-d Avg | 5.28 | 1yr Est | 0.50 |
| Income Statement | |||
| Operating Expenses | 4.98M | ||
| Research and Development Expense | 3.54M | ||
| Selling, General and Administrative Expense | 1.43M | ||
| Operating Income | -4.98M | ||
| Interest Expense | 6.11K | ||
| Net Income | -4.94M | ||
| Net Income Common Stock | -4.94M | ||
| Net Income Common Stock (USD) | -4.94M | ||
| Consolidated Income | -4.94M | ||
| Earnings per Basic Share | -7.30 | ||
| Earnings per Basic Share (USD) | -7.30 | ||
| Earnings per Diluted Share | -7.30 | ||
| Earning Before Interest & Taxes (EBIT) | -4.93M | ||
| Earning Before Interest & Taxes (USD) | -4.93M | ||
| Weighted Average Shares | 676.17K | ||
| Weighted Average Shares Diluted | 676.17K | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.95M | ||
| Cash and Equivalents (USD) | 2.95M | ||
| Current Assets | 4.08M | ||
| Property, Plant & Equipment Net | 22.01K | ||
| Total Assets | 4.65M | ||
| Debt Current | 232.35K | ||
| Total Debt | 232.35K | ||
| Current Liabilities | 4.58M | ||
| Total Liabilities | 4.58M | ||
| Accumulated Retained Earnings (Deficit) | -105.21M | ||
| Shareholders Equity | 70.71K | ||
| Shareholders Equity (USD) | 70.71K | ||
| Assets Non-Current | 574.85K | ||
| Total Debt (USD) | 232.35K | ||
| Trade and Non-Trade Payables | 4.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.87K | ||
| Net Cash Flow from Financing | 404.66K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.25M | ||
| Capital Expenditure | -6.18K | ||
| Issuance (Purchase) of Equity Shares | 500.88K | ||
| Issuance (Repayment) of Debt Securities | -96.22K | ||
| Net Cash Flow from Investing | -6.18K | ||
| Net Cash Flow from Operations | -4.65M | ||
| Share Based Compensation | 2.56K | ||